Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhD

Brendon Neuen, MBBS, PhD, joins hosts to discuss the landmark FLOW trial and its implications on the future of chronic kidney disease management as well as other compelling data surrounding semaglutide from the 61st European Renal Association Congress.



Key Highlights:

00:00 - Intro

01:12 - ERA Recap 

03:06 - FLOW Background

05:20 - FLOW Results

06:56 - FLOW Reaction (Neuen)

09:13 - Semaglutide Mortality Benefit

12:43 - Semaglutide 2.4 in CKD

17:30 - Implementation Science

22:30 - Management Approach